Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
European Archives of Psychiatry and Clinical Neuroscience|September 12, 2022
Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individualsGiulia Braccagni, Simona Scheggi, Marco BortolatoBrain Research Bulletin|February 5, 2022
The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discountingGabriele Floris, Simona Scheggi, Romina Pes, et al.Journal of Neuroendocrinology|August 23, 2021
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?Marco Bortolato, Barbara J Coffey, Vilma Gabbay, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 28, 2020
The adverse effects of pramipexole on probability discounting are not reversed by acute D2 or D3 receptor antagonismMarco Orrù, Hunter J Strathman, Gabriele Floris, et al.Journal of Neuroscience Methods|December 16, 2024
Exploring persistence in animal models: The sinking platform testCaterina Branca, Giulia Braccagni, Dario Finardi, et al.Neurobiology of Stress|December 19, 2022
Acute stress impairs sensorimotor gating via the neurosteroid allopregnanolone in the prefrontal cortexRoberto Cadeddu, Laura J Mosher, Peter Nordkild, et al.Psychoneuroendocrinology|March 16, 2018
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviorsLaura J Mosher, Sean C Godar, Marc Morissette, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2017
The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep DeprivationRoberto Frau, Valentina Bini, Alessio Soggiu, et al.Neurobiology of Disease|September 28, 2018
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionSilvia Fanni, Simona Scheggi, Francesca Rossi, et al.Plos One|January 8, 2020
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic studyNakyung Jeon, Marco BortolatoPageof 19